Our mission and passion are to work for our clients and to combine the strength of our expertise and innovation to advance their success in preventing and curing disease.
REVIO strives to be the premier provider of regulatory advice to biopharmaceutical companies for the development and registration of innovative medicines as ATMPs.
WHO WE ARE
Ex-regulator at the Medicine and Healthcare products Regulatory Agency (MHRA) in the UK as a Pharmaceutical Assessor of registration dossiers.
More than 20 years’ professional experience across Europe mainly in Regulatory Affairs and Product Lifecycle Management of Human Medicinal Products in different biopharmaceutical companies and business models.
She worked as Regulatory Affairs Head in TiGenix (currently Takeda) where among other projects with ATMP, she was actively involved in the successfully approval of the European Marketing Authorization of Alofisel (first authorization for an allogeneic cell therapy product in Europe).
Since April 2019 she established herself as an independent consultant and has collaborated with Biopharmaceutical Companies and Public institutions in the field of ATMPs.
Lecturer in Pharmaceutical Industry Masters.
JOSÉ MANUEL DÍAZ PIQUERAS
Graduated in Biology, with a Master in Virology and a Master in Bioscience Enterprises.
With professional experience as a researcher in a Microbiology Laboratory and as a Pharmaceutical Regulatory Consultant from Alladvice Regulatory Consultants and Revio Pharmaceutical Consultants.
He has worked in different national and international regulatory processes such as Scientific Advice, PRIME, Innovation Task Force Meeting, National Authorizations, Orphan Designation. etc.